Exploring the relationship between co-abundance of gut microbiota and novel metabolic pathways in different subtypes of irritable bowel syndrome: insights from the American Gut Project
BackgroundIrritable bowel syndrome (IBS) is a prevalent functional gastrointestinal disorder with an unclear etiology. Recent studies have underscored the association between alterations in the gut microbiome and the pathogenesis of IBS. However, limited knowledge exists regarding the co-abundance p...
Saved in:
| Main Authors: | Li-li Han, Chun-feng Mei, Hong Xue |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1615717/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ginsenosides and gut microbiota: differential effects on healthy individuals and irritable bowel syndrome subtypes
by: Zhi Du, et al.
Published: (2025-04-01) -
Gut–Brain–Microbiota Axis in Irritable Bowel Syndrome: A Narrative Review of Pathophysiology and Current Approaches
by: Mihaela Stoyanova, et al.
Published: (2025-06-01) -
Cross‐Cohort Gut Microbiome Signatures of Irritable Bowel Syndrome Presentation and Treatment
by: Junhui Li, et al.
Published: (2024-11-01) -
Beyond the Digestive System: Understanding Gut-Brain-Microbiome Axis in Irritable Bowel Syndrome
by: Rashid Ali Khosa, et al.
Published: (2023-07-01) -
Editorial: Recent advances in understanding the role and mechanisms of gut microbiota in inflammatory bowel disease and irritable bowel syndrome
by: Abbas Yadegar, et al.
Published: (2024-11-01)